SCHEMBL29173373

SCHEMBL29173373

CNc1nc(Nc2cnc(N3CCOCC3)c(C#N)c2)c(C(=O)OC)nc1-c1cncc2c1ncn2C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.41
▸ LRRK2 Q5S007 8/20 0.39
▸ KDM4E B2RXH2 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ CDK2 P24941 4/20 0.33
▸ CCNT1 O60563 3/20 0.33
▸ CCNA2 P20248 3/20 0.33
▸ CDK9 P50750 3/20 0.33
▸ CDK1 P06493 2/20 0.32
▸ CCNB1 P14635 2/20 0.32
▸ CDK7 P50613 2/20 0.32
▸ CCNH P51946 2/20 0.32
▸ TRPV1 Q8NER1 1/20 0.32
▸ MAPK10 P53779 1/20 0.32
▸ CCNA1 P78396 1/20 0.32
▸ SRC P12931 1/20 0.32
▸ CCNE1 P24864 1/20 0.32
▸ FLT3 P36888 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206005 1.00 ALDH1A1 (0.41) ALDH1A1LRRK2KDM4EKMT2AMEN1
SCHEMBL24944975 0.92 LRRK2 (0.36) ALDH1A1LRRK2CDK2CCNT1CCNA2
SCHEMBL29173387 0.91 LRRK2 (0.40) ALDH1A1LRRK2CDK2CCNT1CCNA2
SCHEMBL30206049 0.91 LRRK2 (0.40) ALDH1A1LRRK2CDK2CCNT1CCNA2
SCHEMBL30205999 0.91 LRRK2 (0.33) ALDH1A1LRRK2KMT2AMEN1TRPV1
SCHEMBL31577321 0.91 LRRK2 (0.33) ALDH1A1LRRK2KMT2AMEN1TRPV1
SCHEMBL29173512 0.85 PKMYT1 (0.40) LRRK2KMT2AMEN1CDK2CCNA2
SCHEMBL30206202 0.85 PKMYT1 (0.40) LRRK2KMT2AMEN1CDK2CCNA2
SCHEMBL24944973 0.85 CCNT1 (0.33) ALDH1A1LRRK2KDM4ECDK2CCNT1
SCHEMBL30206194 0.85 MEN1 (0.34) LRRK2KMT2AMEN1RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117693503-A Substituted pyrazine-2-carboxamides as HPK1 inhibitors for the treatment of cancer 阿斯利康(瑞典)有限公司 2024-03-12 — — CN disclosed
Send feedback